Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

Sangamo Therapeutics (SGMO) Misses Q4 EPS by 8c, Revenues Miss

February 24, 2021 4:54 PM EST

Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.29), $0.08 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $32.15 million.

We are very pleased with our execution and the progress we made in the... More